Bijal Shah, MD, MS | Authors


Using CAR T-Cell Therapy Earlier May Produce More Benefit in ALL

July 08, 2021

Bijal Shah, MD, MS, discusses the timing of treatment with chimeric antigen receptor T-cell therapy in regard to the data from the ZUMA-3 trial of brexucabtagne autoleucel in patients with acute lymphoblastic leukemia.